Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05404009 · ClinicalTrials.gov registry record
Collecting Dietary Information From People Undergoing Cancer Treatment
A clinical trial of Receiving Allogeneic Hematopoietic Cell Transplants, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05404009 is a study of Receiving Allogeneic Hematopoietic Cell Transplants that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05404009, a study of Receiving Allogeneic Hematopoietic Cell Transplants, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a secure method of collecting dietary and nutritional intake information from people with cancer. The researchers will use this information to learn more about how dietary information may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.
Conditions Studied
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-05-31 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05404009
The ClinicalTrials.gov registry entry for NCT05404009 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Receiving Allogeneic Hematopoietic Cell Transplants appearing as the primary indexed condition, and to 0 interventions.
NCT05404009 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05404009 about?
NCT05404009 is a clinical study titled "Collecting Dietary Information From People Undergoing Cancer Treatment". The purpose of this study is to develop a secure method of collecting dietary and nutritional intake information from people with cancer. The researchers will use this information to learn more about how dietary information may relate to cancer diagnosis and response to treatment, and to identify fa...
What is the current status of trial NCT05404009?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2022-05-31. Estimated completion is 2026-05.
What conditions does trial NCT05404009 study?
This clinical trial studies the following conditions: Receiving Allogeneic Hematopoietic Cell Transplants.
Who is sponsoring clinical trial NCT05404009?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05404009 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.